What is Castle Biosciences's total assets?

Castle Biosciences (CSTL) reported total assets of $547.81M in Q1 2026.

How has Castle Biosciences's total assets changed year-over-year?

Castle Biosciences's total assets increased by 9.2% year-over-year, from $501.72M to $547.81M.

What is the long-term trend for Castle Biosciences's total assets?

Over 5 years (2020 to 2025), Castle Biosciences's total assets has grown at a 5.7% compound annual growth rate (CAGR), from $439.33M to $578.56M.

What does total assets mean?

The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Castle Biosciences CSTL Total Assets

Total Assets at other companies

Labcorp HoldingsLH

$19.09B+8.4%

VeracyteVCYT

$1.44B+9.2%

Personalis, Inc.PSNL

$325.4M+19.1%

NeoGenomicsNEO

$1.35B-15.9%

Fulgent Genetics, Inc.FLGT

$1.16B-4.1%

Cogent Biosciences, Inc.COGT

$903.01M+218%

Segments

By geography

See full

UNITED STATES$547.8M+9.2%

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's total assets?: Castle Biosciences (CSTL) reported total assets of $547.81M in Q1 2026.
How has Castle Biosciences's total assets changed year-over-year?: Castle Biosciences's total assets increased by 9.2% year-over-year, from $501.72M to $547.81M.
What is the long-term trend for Castle Biosciences's total assets?: Over 5 years (2020 to 2025), Castle Biosciences's total assets has grown at a 5.7% compound annual growth rate (CAGR), from $439.33M to $578.56M.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.